Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 7, 2021

Russia approves single dose Covid-19 vaccine Sputnik Light

The Russian Direct Investment Fund (RDIF) has announced that a single dose Covid-19 vaccine called Sputnik Light, obtained authorisation for use in the country.

Continue
Russia approves use of single dose Covid-19 vaccine Sputnik Light. Credit: Gerd Altmann from Pixabay.
March 10, 2021

Japan’s Takeda to acquire the US’ Maverick Therapeutics

Japan-based Takeda Pharmaceutical Company Limited has entered into an agreement to acquire private biopharmaceutical company Maverick Therapeutics, Inc. in a bid to expand its novel immuno-oncology portfolio. Credit: National Cancer Institute/Unsplash
February 9, 2021

USFDA awards Breakthrough Therapy designation to Novartis’ asciminib

Medicines that are being assessed for critical conditions are granted BTD if early clinical evidence indicates significant improvement potential over available therapy. Credit: Vachagan Malkhasyan from Pixabay

Contracts

March 17, 2021

AstraZeneca to deliver 500,000 more doses of AZD7442 to US

AstraZeneca’s long-acting antibody (LAAB) combination AZD7442 is in the late-stage development for the prevention and treatment of the Covid-19 virus. Credit: Steven Cornfield/Unsplash.

Enveric Biosciences signs licensing agreement with Diverse Biotech

Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US

Lilly to provide antibody therapies at Indiana hospitals for treating COVID-19

Deals

Deals April 29, 2021

Pfizer acquires Amplyx Pharmaceuticals

Pharmaceutical Business Review

US clearance granted for AstraZeneca’s proposed acquisition of Alexion

Dr. Reddy’s secures EUA for Sputnik V in India

Sanofi acquires Tidal Therapeutics

Popular

  1. Pfizer-BioNTech Covid-19 vaccine gets Canada approval for adolescents
  2. WHO grants emergency use listing for Moderna’s Covid-19 vaccine
  3. Merck signs voluntary licences with Indian companies on molnupiravir
  4. EMA’s CHMP recommends EU approval for AstraZeneca and Merck’s selumetinib
  5. Study finds PARP inhibitors kill cancer cells with defect in PBRM1 gene

PRESS RELEASES

Cerba Healthcare to Welcome EQT As New Shareholder to Foster Innovation and Continue to Meet the Healthcare Challenges
Cerba Healthcare to Welcome EQT As New Shareholder to Foster Innovation and Continue to Meet the Healthcare Challenges
Webinar – The True Value of FT-IR and Raman as a Quality Control Tool in Pharmaceutical Manufacturing
Webinar – The True Value of FT-IR and Raman as a Quality Control Tool in Pharmaceutical Manufacturing
CBDepot Achieves COSMOS APPROVED Certification for its Isolates
CBDepot Achieves COSMOS APPROVED Certification for its Isolates
Conducting Clinical Trials During Covid-19: Lessons for the Next Pandemic
Conducting Clinical Trials During Covid-19: Lessons for the Next Pandemic
Institut Imagine and Cerba HealthCare Partner to Test for Patients Likely to Develop Severe Symptoms
Institut Imagine and Cerba HealthCare Partner to Test for Patients Likely to Develop Severe Symptoms

Suppliers

Whitepapers

GxP Regulated Industry Assessments of SoftMax Pro Software
GxP Regulated Industry Assessments of SoftMax Pro Software
SnAP Reagents
SnAP Reagents
Diazirines for Photoaffinity Labelling
Diazirines for Photoaffinity Labelling